Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Urogen Pharma Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Urogen Pharma Ltd tiene un total de activos de $285, una ganancia neta loss de $-126

Question 2

¿Cuáles son los ratios financieros clave para URGN?

Accepted Answer

El ratio corriente de Urogen Pharma Ltd es 0.96, el margen neto es -140, las ventas por acción son $2.09.

Question 3

¿Cómo se desglosan los ingresos de Urogen Pharma Ltd por segmento o geografía?

Accepted Answer

Urogen Pharma Ltd largest revenue segment is RTGel Reverse Thermal Hydrogel, at a revenue of 90,398,000 in the most earnings release.For geography, Israel is the primary market for Urogen Pharma Ltd, at a revenue of 90,398,000.

Question 4

¿Es rentable Urogen Pharma Ltd?

Accepted Answer

no, según los últimos estados financieros, Urogen Pharma Ltd tiene una ganancia neta loss de $-126

Question 5

¿Tiene Urogen Pharma Ltd alguna deuda?

Accepted Answer

yes, Urogen Pharma Ltd tiene una deuda de 294

Question 6

¿Cuántas acciones en circulación tiene Urogen Pharma Ltd?

Accepted Answer

Urogen Pharma Ltd tiene un total de acciones en circulación de 42.23

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	94	90	82	64	48	11
Revenue Growth (YoY)	11%	10%	28%	33%	336%	--
Cost of Revenue	10	8	9	7	5	1
Gross Profit	83	81	73	56	42	10
Selling, General & Admin	141	121	93	82	87	90
Research & Development	65	57	45	52	47	47
Operating Expenses	206	178	138	135	135	137
Other Non Operating Income (Expenses)	-21	-23	-20	-21	-17	0
Pretax Income	-150	-124	-98	-108	-109	-125
Income Tax Expense	4	2	3	1	1	3
Net Income	-154	-126	-102	-109	-110	-128
Net Income Growth	36%	24%	-6%	-1%	-14%	22%
Shares Outstanding (Diluted)	47.73	42.87	28.83	22.81	22.35	21.78
Shares Change (YoY)	30%	49%	26%	2%	3%	6%
EPS (Diluted)	-3.24	-2.95	-3.54	-4.81	-4.96	-5.9
EPS Growth	5%	-17%	-26%	-3%	-16%	15%
Free Cash Flow	-123	-97	-76	-87	-85	-107
Free Cash Flow Per Share	-2.57	-2.26	-2.63	-3.81	-3.8	-4.91
Gross Margin	88.29%	90%	89.02%	87.5%	87.5%	90.9%
Operating Margin	-130.85%	-106.66%	-79.26%	-123.43%	-191.66%	-1,145.45%
Profit Margin	-163.82%	-140%	-124.39%	-170.31%	-229.16%	-1,163.63%
Free Cash Flow Margin	-130.85%	-107.77%	-92.68%	-135.93%	-177.08%	-972.72%
EBITDA	-123	-96	-65	-79	-92	-126
EBITDA Margin	-130.85%	-106.66%	-79.26%	-123.43%	-191.66%	-1,145.45%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-123	-96	-65	-79	-92	-126
EBIT Margin	-130.85%	-106.66%	-79.26%	-123.43%	-191.66%	-1,145.45%
Effective Tax Rate	-2.66%	-1.61%	-3.06%	-0.92%	-0.91%	-2.4%

Urogen Pharma Ltd (URGN) Price

URGN Stock Price Chart

URGN Income

Follow-Up Questions